# Rentschler Biopharma SE – FDA Inspection, May 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/f2b2eb28-9fc0-4b27-a968-da94072cd325
Source feed: FDA_Inspections

> FDA inspection 1022082 of Rentschler Biopharma SE, May 23, 2017. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1022082
- Company Name: Rentschler Biopharma SE
- Inspection Date: 2017-05-23
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1246782 - 2023-05-05](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/0d912736-9230-4aef-96a6-874067c47f8c)
- [FDA Inspection 1202157 - 2023-03-07](https://www.keypedia.com/records/fda_inspections/rentschler-biopharma-se/300ac9e9-db9e-4c2e-a99e-94a03668b9ed)
- FDA Inspection 1160831 - 2021-02-26
- FDA Inspection 1102650 - 2019-08-09
- FDA Inspection 1046488 - 2018-03-08

## Related Officers

- Issuing Officer
- Issuing Officer
- Issuing Officer

Company: https://www.keypedia.com/companies/rentschler-biopharma-se/da50fa41-24f6-449f-bf90-45eccb97d9ba

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8